Conquering the Multiple Myeloma Continuum
December 2015 Vol 6, No 6 | January 4, 2016
Oral oncolytics offer the ease of self-administration to patients. There is
no prodding for stubborn veins, and no need for a port. Therefore, oral therapies
empower patients, and often lead to improved quality of life.
December 2015 Vol 6, No 6 | January 4, 2016
Treating cancer with oral medications that are taken at home sounds like a great
idea, and it is, once adherence barriers are addressed. Likewise, years ago it was
unthinkable that surviving cancer would have a downside, but because late
and long-term effects of cancer treatments were not adequately addressed, survivorship
quality was suboptimal. The good news is that if survivorship issues can be resolved,
so can the problems associated with oral therapy adherence.
December 2015 Vol 6, No 6 | January 4, 2016
Aaron D. Bleznak, MD, MBA, FACS discussed
the intent of the new 2012 Commission on Cancer
(CoC) standards, and what navigators need to do to
comply. “You’re members of a team whose goal is to enhance
the quality of cancer care that you’re providing to
your patient population,” he said at the Sixth Annual
Academy of Oncology Nurse & Patient Navigators
(AONN+) Conference in Atlanta, GA. “Consequently,
you have to work with the team to achieve accreditation,
and retain accreditation.”
Results 1 - 3 of 3
